Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
Apogossypolone (ApoG2)
Cat No.
CEI-0937
Description
Apogossypolone (ApoG2) is a pan Bcl-2 inhibitor for Bcl-2, Bcl-XL and Mcl-1 with IC50 of 35 nM, 660 nM and 25 nM, respectively.
CAS No.
886578-07-0
Molecular Weight
490.5
Storage
2 years -20 centigrade Powder; 2 weeks 4 centigrade in DMSO; 6 months -80 centigrade in DMSO.
Targets
Bcl-2, Bcl-XL, Mcl-1
IC50
35 nM; 660 nM; 25 nM
Molecular Formula
C28H26O8
Chemical Name
[2,2'-Binaphthalene]-1,1',4,4'-tetrone, 6,6',7,7'-tetrahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)-
Solubility
DMSO mg/mL; Water mg/mL; Ethanol mg/mL
In vitro
Apogossypolone (ApoG2) is a semi-synthesized derivative of Gossypol. ApoG2 is a pan Bcl-2 inhibitor for Bcl-2, Bcl-XL and Mcl-1 with IC50 of 35 nM, 660 nM and 25 nM, respectively. ApoG2 blocks the formation of heterodimers between Bcl-XL and Bim. ApoG2 effectively inhibits growth of DLCL2 cells at least partly by inducing apoptosis, with IC50 of 350 nM for a treatment of 72 h. ApoG2 inhibits the growth of WSU-FSCCL, with IC50 of 109 nM, and decreases cell number of fresh lymphoma cells. ApoG2 activates caspases-9, -3, and -8, and the cleavage of PARP and AIF.ApoG2 selectively inhibits the proliferation of 3 nasopharyngeal carcinoma (NPC) cell lines (C666-1, CNE-1 and CNE-2) that highly expresses Bcl-2 proteins, with IC50 values of 1.7, 2.055, 4.915 μM.ApoG2 inhibits proliferation of breast cancer cell line MCF-7 by inducing cell apoptosis and autophagy, with 89.20% inhibition for ApoG2 at 40 μM at 72 h.ApoG2 induces ER stress-dependent apoptosis in gastric cancer cells, with IC50 of 18.7 μM at 72 h.
In vivo
ApoG2 treatment at 600 mg/kg results in significant growth inhibition of WSU-DLCL2 xenografts. In the WSU-FSCCL-SCID xenograft model, ApoG2 shows a significant antilymphoma effect, with %ILS of 84% in the intravenous and 63% in intraperitoneal treated mice.ApoG2 effectively suppresses tumor growth of NPC xenografts in nude mice.ApoG2 has anticancer effect in subcutaneous gastric cancer cell xenografts in mice.
Download
Download Datasheet